نبذة مختصرة : The aryloxy triester phosphoramidate prodrug approach has been used with success in drug discovery. Herein, we describe the first application of this prodrug technology to the monophosphate derivative of the phosphoantigen HMBPP and one of its analogues. Some of these prodrugs exhibited specific and potent activation of Vγ9/Vδ2 T-cells, which were then able to lyse bladder cancer cells in vitro. This work highlights the promise of this prodrug technology in the discovery of novel immunotherapeutics.
Relation: https://orca.cardiff.ac.uk/id/eprint/109366/7/acs.jmedchem.7b01824.pdf; Davey, Martin S., Malde, Roshni, Mykura, Rory C., Baker, Alfie T., Taher, Taher E., Le Duff, Cécile S., Willcox, Benjamin E. and Mehellou, Youcef https://orca.cardiff.ac.uk/view/cardiffauthors/A2298834Y.html orcid:0000-0001-5720-8513 orcid:0000-0001-5720-8513 2018. Synthesis and biological evaluation of (E)-4-hydroxy-3-methylbut2-enyl phosphate (HMBP) aryloxy triester phosphoramidate Prdrugs as activators of Vγ9/Vδ2 T-cells immune response. Journal of Medicinal Chemistry 61 (5) , pp. 2111-2117. 10.1021/acs.jmedchem.7b01824 https://doi.org/10.1021/acs.jmedchem.7b01824 file https://orca.cardiff.ac.uk/id/eprint/109366/7/acs.jmedchem.7b01824.pdf
Processing Request
No Comments.